Similar articles

• The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.

  Benson JR. Benson JR. J Clin Oncol. 2005 Sep 20;23(27):6807-9. doi: 10.1200/JCO.2005.02.3952. J Clin Oncol. 2005. PMID: 16170197 No abstract available.
• Systemic (adjuvant) treatment of primary breast cancer.

  Somani N. Somani N. J Assoc Physicians India. 2001 Apr;49:451-3. J Assoc Physicians India. 2001. PMID: 11762618 Review.
• Recent advances in the hormonal treatment of breast cancer.

  Boughey JC, Buzdar AU, Hunt KK. Boughey JC, et al. Curr Probl Surg. 2008 Jan;45(1):13-55. doi: 10.1067/j.cpsurg.2007.10.004. Curr Probl Surg. 2008. PMID: 18206436 Review. No abstract available.
• Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: an old(er) problem.

  Schott A, Hayes DF. Schott A, et al. J Clin Oncol. 2004 Dec 1;22(23):4660-2. doi: 10.1200/JCO.2004.07.961. Epub 2004 Oct 25. J Clin Oncol. 2004. PMID: 15505274 No abstract available.
• Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients.

  Saarto T, Vehmanen L, Virkkunen P, Blomqvist C. Saarto T, et al. Acta Oncol. 2004;43(7):650-6. doi: 10.1080/02841860410032885. Acta Oncol. 2004. PMID: 15545185 Clinical Trial.